Global /China /Healthcare /Medical Devices /688298

Zhejiang Orient Gene Biotech Co., Ltd.

688298

• SSE: 688298 • Delayed

22.33CNY 0.7%

3.30 USD

As of 16 June 2026, Zhejiang Orient Gene Biotech Co., Ltd. has a market cap of $632.82M USD, ranking #13595 globally and #4146 in China. It ranks #1220 in the Healthcare sector, and #244 in the Medical Devices industry.

Global Rank

13595

Country Rank

4146

Sector Rank

1220

Industry Rank

244

Key Stats

Market Cap

$632.82MUSD

4.29B CNY

Enterprise Value

$315.0MUSD

2.13B CNY

Revenue (TTM)

$139.91MUSD

947.38M CNY

EBITDA (TTM)

-$39.56MUSD

-267.74M CNY

Net Income (TTM)

-$84.71MUSD

-573.6M CNY

EBITDA Margin

-28%

Profit Margin

-61%

PS Ratio

4.5

PB Ratio

0.7

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Medical Devices

CEO

Xiaoliang Fang open_in_new

Employees

2,434

Founded

2005

Website

orientgene.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.7%	0.9%	-2%	-12%	-11%	-4.8%	2.8%	-55%	-78%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	688298 浙江东方基因生物制品股份有限公司 Class A ISIN: CNE100003RM8 Shares Out.: Shares Outstanding: 191.395M¹ Shares Float: 94.882M² TV: TradingView: SSE: 688298 SA: Stock Analysis: SHA: 688298 YF: Yahoo Finance: 688298.SS GF: Google Finance: SHA: 688298 BA: Barron's: 688298 MS: Morningstar: XSHG: 688298	22.33 CNY	TV: TradingView: SSE: 688298 SA: Stock Analysis: SHA: 688298 YF: Yahoo Finance: 688298.SS GF: Google Finance: SHA: 688298 BA: Barron's: 688298 MS: Morningstar: XSHG: 688298

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Zhejiang Orient Gene Biotech Co., Ltd.

Zhejiang Orient Gene Biotech Co., Ltd researches and develops, produces, and sells in vitro diagnostic products worldwide. Its products include POCT instant diagnostic reagents, used for detection of infectious diseases, drugs of abuse, fertility, tumor marker, and cardiac marker detection. The company offers its products for various categories, including COVID-19 diagnosis solutions; immunological diagnosis; quantum-beads flowcytometry; instrument; dry biochemical strips; raw materials; FISH probes; animal health; biochemistry; molecular diagnosis; and quantum-beads multiplex. Zhejiang Orient Gene Biotech Co., Ltd was founded in 2005 and is based in Huzhou, China.

Similar Companies

Industry: Medical Devices (China)

Name	Market Cap (USD) diff.	PE	Country
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. SHE: 300760	$30.08B 203.66B CNY 5K%	26.0	China
Shanghai United Imaging Healthcare Co., Ltd. SSE: 688271	$13.62B 92.23B CNY 2K%	48.5	China
Shenzhen New Industries Biomedical Engineering Co., Ltd. SHE: 300832	$5.61B 38.02B CNY 787%	23.4	China
Intco Medical Technology Co., Ltd. SHE: 300677	$5.53B 37.43B CNY 773%	52.7	China
APT Medical Inc. SSE: 688617	$5.04B 34.14B CNY 697%	39.6	China
Andon Health Co., Ltd. SHE: 002432	$4.56B 30.86B CNY 620%	13.7	China

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 27K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 25K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 25K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 20K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 19K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 16K%	22.2	Ireland

chevron_leftBack